We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+24.79%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$5.35B
AUM Growth
+$618M
Cap. Flow
-$201M
Cap. Flow %
-3.76%
Top 10 Hldgs %
6.31%
Holding
1,443
New
140
Increased
372
Reduced
393
Closed
90

Top Buys

Rank Stock Value
1
UI icon
Ubiquiti
UI
+$17.9M
2
CCI icon
Crown Castle
CCI
+$17.4M
3
FCX icon
Freeport-McMoran
FCX
+$16.9M
4
PAYX icon
Paychex
PAYX
+$16.7M
5
PINS icon
Pinterest
PINS
+$16.5M

Sector Composition

Rank Sector Weight
1 Financials 23.41%
2 Industrials 12.44%
3 Consumer Discretionary 11.7%
4 Technology 11.45%
5 Healthcare 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSY
1326
DELISTED
SunLink Health Systems
SSY
$109K ﹤0.01%
+40,000
New +$78.8K
FUSB icon
1327
First US Bancshares
FUSB
$91.1M
$107K ﹤0.01%
11,468
TMBR
1328
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$103K ﹤0.01%
1,010
-2,156
-68% -$186K
INBS icon
1329
Intelligent Bio Solutions
INBS
$4.74M
$102K ﹤0.01%
+8
New +$138K
OCC icon
1330
Optical Cable Corp
OCC
$143M
$100K ﹤0.01%
27,600
+7,500
+37% +$26.9K
ITP icon
1331
IT Tech Packaging
ITP
$2.99M
$97K ﹤0.01%
14,700
ACGN
1332
DELISTED
Aceragen Inc
ACGN
$94K ﹤0.01%
+4,251
New +$318K
ARTW icon
1333
Arts-Way Manufacturing Co
ARTW
$11.4M
$93K ﹤0.01%
30,000
HIND
1334
Vyome Holdings
HIND
$15.2M
0
ADXS
1335
DELISTED
Advaxis Inc
ADXS
$88K ﹤0.01%
120,000
-155,600
-56% -$127K
ATRS
1336
DELISTED
Antares Pharma, Inc.
ATRS
$83K ﹤0.01%
+20,100
New +$87.1K
AWX icon
1337
Avalon Holdings
AWX
$10.1M
$79K ﹤0.01%
21,600
PFIN
1338
DELISTED
P&F Industries
PFIN
$77K ﹤0.01%
11,688
TOVX icon
1339
Theriva Biologics
TOVX
$10.1M
$75K ﹤0.01%
437
TWAV
1340
TaoWeave Inc
TWAV
$4.42M
$73K ﹤0.01%
24
HPR
1341
DELISTED
HighPoint Resources Corporation
HPR
$73K ﹤0.01%
13,436
-21,000
-61% -$197K
ERNA icon
1342
Eterna Therapeutics
ERNA
$4.91M
$65K ﹤0.01%
+2
New +$108K
BDR
1343
DELISTED
Blonder Tongue Laboratories Inc
BDR
$59K ﹤0.01%
40,000
-270,100
-87% -$424K
AGIG
1344
Abundia Global Impact Group
AGIG
$36.5M
$57K ﹤0.01%
2,800
PFIE
1345
DELISTED
Profire Energy, Inc
PFIE
$55K ﹤0.01%
50,000
-134,700
-73% -$155K
ENSV
1346
DELISTED
Enservco Corp.
ENSV
$54K ﹤0.01%
31,000
MDIA icon
1347
Mediaco Holding
MDIA
$78M
$43K ﹤0.01%
12,992
-329
-2% -$1.13K
SGRP
1348
DELISTED
SPAR Group
SGRP
$42K ﹤0.01%
+25,000
New +$38.3K
SONM icon
1349
DNA X Inc
SONM
$5.63M
$36K ﹤0.01%
24
-84
-78% -$148K
TLGT
1350
DELISTED
Teligent, Inc
TLGT
$31K ﹤0.01%
+50,000
New +$47.1K

Similar funds

Bridgeway Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Bridgeway Capital Management held 1,443 positions worth $5.35B, up 13% from $4.73B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Bridgeway Capital Management withdrew a net $201M in Q1 2021, closing 90 positions and reducing 393 holdings. Its most notable exit was Republic Services, an estimated $20.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Bridgeway Capital Management opened a new position in Ubiquiti worth $16.9M.

  • Bridgeway Capital Management's largest Q1 2021 buy was Ubiquiti: 56,745 shares worth $16.9M.
  • Bridgeway Capital Management added most to Crown Castle in Q1 2021, an estimated $17.4M increase.
  • Bridgeway Capital Management's biggest Q1 2021 reduction was Warner Bros, cutting an estimated $13.9M.
  • Bridgeway Capital Management fully exited Republic Services in Q1 2021, selling an estimated $20.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.3% of its $5.35B portfolio in Q1 2021.
  • Bridgeway Capital Management opened 140 new positions and closed 90 in Q1 2021.
  • Bridgeway Capital Management's portfolio value rose 13% quarter-over-quarter to $5.35B.

Based on Bridgeway Capital Management's 13F filing for Q1 2021, filed 17 May 2021.